1. Home
  2. NMRA vs CIVB Comparison

NMRA vs CIVB Comparison

Compare NMRA & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • CIVB
  • Stock Information
  • Founded
  • NMRA 2019
  • CIVB 1884
  • Country
  • NMRA United States
  • CIVB United States
  • Employees
  • NMRA N/A
  • CIVB N/A
  • Industry
  • NMRA
  • CIVB Major Banks
  • Sector
  • NMRA
  • CIVB Finance
  • Exchange
  • NMRA Nasdaq
  • CIVB Nasdaq
  • Market Cap
  • NMRA 287.6M
  • CIVB 305.3M
  • IPO Year
  • NMRA 2023
  • CIVB N/A
  • Fundamental
  • Price
  • NMRA $0.65
  • CIVB $19.86
  • Analyst Decision
  • NMRA Buy
  • CIVB Buy
  • Analyst Count
  • NMRA 8
  • CIVB 4
  • Target Price
  • NMRA $9.29
  • CIVB $22.67
  • AVG Volume (30 Days)
  • NMRA 1.2M
  • CIVB 44.2K
  • Earning Date
  • NMRA 05-06-2025
  • CIVB 04-24-2025
  • Dividend Yield
  • NMRA N/A
  • CIVB 3.42%
  • EPS Growth
  • NMRA N/A
  • CIVB N/A
  • EPS
  • NMRA N/A
  • CIVB 2.01
  • Revenue
  • NMRA N/A
  • CIVB $149,094,000.00
  • Revenue This Year
  • NMRA N/A
  • CIVB $15.59
  • Revenue Next Year
  • NMRA N/A
  • CIVB $5.38
  • P/E Ratio
  • NMRA N/A
  • CIVB $9.88
  • Revenue Growth
  • NMRA N/A
  • CIVB N/A
  • 52 Week Low
  • NMRA $0.62
  • CIVB $13.60
  • 52 Week High
  • NMRA $17.19
  • CIVB $23.70
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 22.34
  • CIVB 54.01
  • Support Level
  • NMRA $0.64
  • CIVB $18.80
  • Resistance Level
  • NMRA $0.83
  • CIVB $20.26
  • Average True Range (ATR)
  • NMRA 0.09
  • CIVB 1.01
  • MACD
  • NMRA 0.02
  • CIVB 0.10
  • Stochastic Oscillator
  • NMRA 6.68
  • CIVB 83.57

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

Share on Social Networks: